FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Andrew Muir

Research Profile

Disorders

Chemicals & Drugs

Living Beings

Hepacivirus

Physiology

Genotype

Procedures

Concepts & Ideas

Genes & Molecular Sequences

Single Nucleotide Polymorphism

Geographic Areas

United States

Co-author Network

Publications

TOP 3
Frank E Luke; Christopher M Massey; Sara T Moshiri; Andrew J Muir; Sandra S Stinnett; Brian C Allen; Lisa M Ho; Tracy A Jaffe
Multiphase multi-detector row computed tomography in the setting of chronic liver disease and orthotopic liver transplantation: can a series be eliminated in order to reduce radiation dose?
Andrew J Muir
IL28B in the era of direct-acting antivirals for hepatitis C.
Janice H Jou; Andrew J Muir
In the clinic. Hepatitis C.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Andrew Muir (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Frank E Luke; Christopher M Massey; Sara T Moshiri; Andrew J Muir; Sandra S Stinnett; Brian C Allen; Lisa M Ho; Tracy A Jaffe
Multiphase multi-detector row computed tomography in the setting of chronic liver disease and orthotopic liver transplantation: can a series be eliminated in order to reduce radiation dose?
Journal of computer assisted tomography 2013;37(3):408-14.
2013: Andrew J Muir
IL28B in the era of direct-acting antivirals for hepatitis C.
Journal of clinical gastroenterology 2013;47(3):222-7.
2012: Janice H Jou; Andrew J Muir
In the clinic. Hepatitis C.
Annals of internal medicine 2012;157(11):ITC6-1 - ITC6-16.
2012: Andrew J Muir
Approach to the treatment-naïve patient with HCV genotype 1 infection.
Infectious disease clinics of North America 2012;26(4):893-901.
2012: Ziad F Gellad; Ira M Jacobson; David Kershenobich; Michael P Manns; John G McHutchison; Andrew J Muir; Kimberly A Brown; Robert Flisiak; Kevin A Schulman; Ala I Sharara; William Sievert; Shelby D Reed
Cost-effectiveness of truncated therapy for hepatitis C based on rapid virologic response.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2012;15(6):876-86.
2012: Brianna L Norton; Lawrence Park; Rae Jean Proeschold Bell; Leah J McGrath; Andrew J Muir; Susanna Naggie
Health care utilization in HIV-infected patients: assessing the burden of hepatitis C virus coinfection.
AIDS patient care and STDs 2012;26(9):541-5.
2012: Paul J Clark; Jacques Fellay; Dongliang Ge; David B Goldstein; Zachary Goodman; Stephen A Harrison; John G McHutchison; Susanna Naggie; Stephanie Noviello; Keyur Patel; Lisa Pedicone; Kevin Shianna; Mark S Sulkowski; Alexander J Thompson; Hans L Tillmann; Thomas J Urban; David M Vock; Mingfu Zhu; Qianqian Zhu; Nezam Afdhal; Janice K Albrecht; Andrew J Muir
The association of genetic variants with hepatic steatosis in patients with genotype 1 chronic hepatitis C infection.
Digestive diseases and sciences 2012;57(8):2213-21.
2012: Susanna Naggie; Anu Osinusi; Keyur Patel; Michael A Polis; Joerg F Schlaak; Bhavana Shivakumar; Alexander J Thompson; Martin Trippler; Paul J Clark; Eva Herrmann; Antonios Katsounas; Richard Lempicki; Henry Masur; John G McHutchison; Andrew J Muir; Shyam Kottilil
Dysregulation of innate immunity in hepatitis C virus genotype 1 IL28B-unfavorable genotype patients: impaired viral kinetics and therapeutic response.
Hepatology (Baltimore, Md.) 2012;56(2):444-54.
2012: Paul J Clark; Andrew J Muir
Lost in translation? IL28B's discovery and the journey back to the patient.
Hepatology (Baltimore, Md.) 2012;56(1):5-8.
2012: Paul J Clark; Richard I Kelley; Lisa Kratz; John G McHutchison; David M Millington; Andrew J Muir; G. SUBRAMANIAN; Alexander J Thompson; Adviye A Tolun; David M Vock; Keyur Patel
Hepatitis C virus selectively perturbs the distal cholesterol synthesis pathway in a genotype-specific manner.
Hepatology (Baltimore, Md.) 2012;56(1):49-56.
2012: Paul J Clark; Andrew J Muir
Overcoming barriers to care for hepatitis C.
The New England journal of medicine 2012;366(26):2436-8.
2012: Andrew J Muir
Surgical clearance for the patient with chronic liver disease.
Clinics in liver disease 2012;16(2):421-33.
2012: P J Clark; R Esteban; Jacques Fellay; D Ge; David B Goldstein; S A Harrison; Paul Y Kwo; John G McHutchison; Andrew J Muir; S Naggie; S Noviello; Keyur Patel; Lisa Pedicone; K Shianna; Mark S Sulkowski; A J Thompson; Hans L Tillmann; T J Urban; D M Vock; M Zhu; Q Zhu; Nezam H Afdhal; Janice K Albrecht
Interleukin 28B polymorphisms are the only common genetic variants associated with low-density lipoprotein cholesterol (LDL-C) in genotype-1 chronic hepatitis C and determine the association between LDL-C and treatment response.
Journal of viral hepatitis 2012;19(5):332-40.
2012: Rae Jean Proeschold-Bell; Jia Yao; Susanna Naggie; Ashwin A Patkar; Patricia Bixby; Lesleyjill Coward; Paolo Mannelli; Andrew J Muir
An integrated alcohol abuse and medical treatment model for patients with hepatitis C.
Digestive diseases and sciences 2012;57(4):1083-91.
2012: Alexander J Thompson; Hans L Tillmann; Thomas J Urban; Mingfu Zhu; Qianqian Zhu; Susanna Naggie; Stephanie Noviello; Keyur Patel; Lisa Pedicone; F Fred Poordad; Kevin V Shianna; Mitchell L Shiffman; Abanish Singh; Mark S Sulkowski; Nezam H Afdhal; Janice K Albrecht; Clifford A Brass; Paul J Clark; Rafael Esteban; Jacques Fellay; Greg W Galler; Dongliang Ge; David B Goldstein; Ira M Jacobson; John W King; Paul Y Kwo; Eric J Lawitz; Jonathan McCone; John G McHutchison; Andrew J Muir
Genome-wide association study of interferon-related cytopenia in chronic hepatitis C patients.
Journal of hepatology 2012;56(2):313-9.
2012: Ziad F Gellad; Shelby D Reed; Andrew J Muir
Economic evaluation of direct-acting antiviral therapy in chronic hepatitis C.
Antiviral therapy 2012;17(6 Pt B):1189-99.
2011: Andrew J Muir
Telaprevir for the treatment of chronic hepatitis C infection.
Expert review of anti-infective therapy 2011;9(12):1105-14.
2011: Hans L Tillmann; Paul J Clark; Stephen D Gardner; CD Guy; Xiang Qian Lao; Josephine H Li; John G McHutchison; Andrew J Muir; Keyur Patel; Alexander Thompson; Jeanette J McCarthy
Beneficial IL28B genotype associated with lower frequency of hepatic steatosis in patients with chronic hepatitis C.
Journal of hepatology 2011;55(6):1195-200.
2011: Andrew J Muir; Jean-Michel Pawlotsky; F Fred Poordad; Henk W Reesink; Mitchell L Shiffman; Stefan Zeuzem; Thomas Berg; Geoffrey Dusheiko; Peter Ferenci; Shelley George; E Jenny Heathcote; Robert S Kauffman; Emily C Martin; John G McHutchison; Nathalie Adda
Retreatment with telaprevir combination therapy in hepatitis C patients with well-characterized prior treatment response.
Hepatology (Baltimore, Md.) 2011;54(5):1538-46.
2011: Rae Jean Proeschold-Bell; Beth Stringfield; Baishakhi Taylor; Rachel Blouin; Sarah Cohen; Bettina Hoeppner; Andrew J Muir
An interrupted time series evaluation of a hepatitis C intervention for persons with HIV.
AIDS and behavior 2011;15(8):1721-31.
2011: Alison B Jazwinski; Andrew J Muir
Emerging therapies in hepatitis C: dawn of the era of the direct-acting antivirals.
Gastroenterology clinics of North America 2011;40(3):481-94.
2011: Michael THOMAS Melia; Andrew J Muir; Kevin D Mullen; Stephanie Noviello; Frederick A Nunes; Natarajan Ravendhran; Mitchell L Shiffman; Mark S Sulkowski; Janice K Albrecht; Joseph R Bloomer; Navdeep Boparai; Clifford A Brass; Kimberly A Brown; Greg W Galler; Reem H Ghalib; Steven K Herrine; Ruiyun Jiang; John W King; Jonathan McCone; John G McHutchison
Racial differences in hepatitis C treatment eligibility.
Hepatology (Baltimore, Md.) 2011;54(1):70-8.
2011: Ira M Jacobson; Robert S Kauffman; Tara L Kieffer; Patrick Marcellin; John G McHutchison; Andrew J Muir; K Rajender Reddy; Mario Rizzetto; Abdul J Sankoh; Daniel Shouval; Ricard Sola; Ruben A Terg; Eric M Yoshida; Stefan Zeuzem; Nathalie Adda; Leif Bengtsson; Natalie H Bzowej; Adrian M Di Bisceglie; Geoffrey Dusheiko; Peter Ferenci; Robert Flisiak; Jacob George; Shelley George
Telaprevir for previously untreated chronic hepatitis C virus infection.
The New England journal of medicine 2011;364(25):2405-16.
2011: Andrew J Muir
The protease inhibitor era: an opportunity to improve the quality of care.
Digestive diseases and sciences 2011;56(5):1252-4.
2011: Alison B Jazwinski; Andrew J Muir
Direct-acting antiviral medications for chronic hepatitis C virus infection.
Gastroenterology & hepatology 2011;7(3):154-62.
2011: Alexander J Thompson; Rosanna Santoro; Valeria Piazzolla; Paul J Clark; Susanna Naggie; Hans L Tillmann; Keyur Patel; Andrew J Muir; Kevin V Shianna; Leonardo Mottola; Daniela Petruzzellis; Mario Romano; Fernando Sogari; Domenico Facciorusso; David B Goldstein; John G McHutchison; alessandra mangia
Inosine triphosphatase genetic variants are protective against anemia during antiviral therapy for HCV2/3 but do not decrease dose reductions of RBV or increase SVR.
Hepatology (Baltimore, Md.) 2011;53(2):389-95.
2010: Alexander J Thompson; Andrew J Muir; Mark S Sulkowski; Keyur Patel; Hans L Tillmann; Paul J Clark; Susanna Naggie; Jacques Fellay; Dongliang Ge; Jeanette J McCarthy; David B Goldstein; John G McHutchison
Hepatitis C trials that combine investigational agents with pegylated interferon should be stratified by interleukin-28B genotype.
Hepatology (Baltimore, Md.) 2010;52(6):2243-4.
2010: Janice H Jou; Po-Hung Chen; Alison Jazwinski; Iliana Bouneva; AD Smith; Andrew J Muir
Rates of surveillance and management of hepatocellular carcinoma in patients evaluated at a liver transplant center.
Digestive diseases and sciences 2010;55(12):3591-6.
2010: Donald E Bailey; Julie Barroso; Andrew J Muir; Richard Sloane; Jacqui Richmond; John McHutchison; Keyur Patel; Lawrence Landerman; Merle H Mishel
Patients with chronic hepatitis C undergoing watchful waiting: Exploring trajectories of illness uncertainty and fatigue.
Research in nursing & health 2010;33(5):465-73.
2010: Alexander J Thompson; Jacques Fellay; Keyur Patel; Hans L Tillmann; Susanna Naggie; Dongliang Ge; Thomas J Urban; Kevin V Shianna; Andrew J Muir; Michael W Fried; Nezam H Afdhal; David B Goldstein; John G McHutchison
Variants in the ITPA gene protect against ribavirin-induced hemolytic anemia and decrease the need for ribavirin dose reduction.
Gastroenterology 2010;139(4):1181-9.
2010: Andrew J Muir; Mitchell L Shiffman; Atif Zaman; Boris Yoffe; Andrew de la Torre; Steven Flamm; Stuart Gordon; Paul Marotta; John M Vierling; Juan Carlos Lopez-Talavera; Kelly Byrnes-Blake; David Fontana; Jeremy Freeman; Todd Gray; Diana Hausman; Naomi N Hunder; Eric Lawitz
Phase 1b study of pegylated interferon lambda 1 with or without ribavirin in patients with chronic genotype 1 hepatitis C virus infection.
Hepatology (Baltimore, Md.) 2010;52(3):822-32.
2010: J M Castor; R K Wood; Andrew J Muir; Scott M Palmer; R A Shimpi
Gastroesophageal reflux and altered motility in lung transplant rejection.
Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 2010;22(8):841-50.
2010: Rae Jean Proeschold-Bell; Rachel Blouin; Susan Reif; Arit Amana; Benjamin J Rowland; Frank Lombard; Beth Stringfield; Andrew J Muir
Hepatitis C transmission, prevention, and treatment knowledge among patients with HIV.
Southern medical journal 2010;103(7):635-41.
2010: Jeanette J McCarthy; Josephine H Li; Alexander Thompson; Sunil Suchindran; Xiang Qian Lao; Keyur Patel; Hans L Tillmann; Andrew J Muir; John G McHutchison
Replicated association between an IL28B gene variant and a sustained response to pegylated interferon and ribavirin.
Gastroenterology 2010;138(7):2307-14.
2010: Jacqueline A Richmond; Donald E Bailey; John G McHutchison; Andrew J Muir
The use of mind-body medicine and prayer among adult patients with chronic hepatitis C.
Gastroenterology nursing : the official journal of the Society of Gastroenterology Nurses and Associates 2010;33(3):210-6.
2010: John G McHutchison; Michael P Manns; Andrew J Muir; Norah A Terrault; Ira M Jacobson; Nezam H Afdhal; E Jenny Heathcote; Stefan Zeuzem; Hendrik W Reesink; Jyotsna Garg; Mohammad Bsharat; Shelley George; Robert S Kauffman; Nathalie Adda; Adrian M Di Bisceglie
Telaprevir for previously treated chronic HCV infection.
The New England journal of medicine 2010;362(14):1292-303.
2010: Jacques Fellay; Alexander J Thompson; Dongliang Ge; Curtis Gumbs; Thomas J Urban; Kevin V Shianna; Latasha D Little; Ping Qiu; Arthur H Bertelsen; Mark Watson; Amelia Warner; Andrew J Muir; Clifford Brass; Janice Albrecht; Mark S Sulkowski; John G McHutchison; David B Goldstein
ITPA gene variants protect against anaemia in patients treated for chronic hepatitis C.
Nature 2010;464(7287):405-8.
2009: Dongliang Ge; Jacques Fellay; Alexander J Thompson; Jason S Simon; Kevin V Shianna; Thomas J Urban; Erin L Heinzen; Ping Qiu; Arthur H Bertelsen; Andrew J Muir; Mark S Sulkowski; John G McHutchison; David B Goldstein
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance.
Nature 2009;461(7262):399-401.
2009: John G McHutchison; Eric J Lawitz; Mitchell L Shiffman; Andrew J Muir; Greg W Galler; Jonathan McCone; Lisa M Nyberg; William M Lee; Reem H Ghalib; Eugene R Schiff; Joseph S Galati; Bruce R Bacon; Mitchell N Davis; Pabak Mukhopadhyay; Kenneth Koury; Stephanie Noviello; Lisa Pedicone; Clifford A Brass; Janice K Albrecht; Mark S Sulkowski
Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection.
The New England journal of medicine 2009;361(6):580-93.
2009: Donald E Bailey; Lawrence Landerman; Julie Barroso; Patricia Bixby; Merle H Mishel; Andrew J Muir; Lisa Strickland; Elizabeth C Clipp
Uncertainty, symptoms, and quality of life in persons with chronic hepatitis C.
Psychosomatics 2009;50(2):138-46.
2008: Cynthia A Moylan; Carla W Brady; Jeffrey L Johnson; Alastair D Smith; Janet E Tuttle-Newhall; Andrew J Muir
Disparities in liver transplantation before and after introduction of the MELD score.
JAMA : the journal of the American Medical Association 2008;300(20):2371-8.
2008: Carla W Brady; Alastair D Smith; Karen M Stechuchak; Cynthia J Coffman; Janet E Tuttle-Newhall; Dawn Provenzale; Andrew J Muir
Frequency and predictors of de novo hepatocellular carcinoma in patients awaiting orthotopic liver transplantation during the model for end-stage liver disease era.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2008;14(2):228-34.
2007: Z F Gellad; Barbara D Alexander; J K Liu; B C Griffith; A M Meyer; J L Johnson; Andrew J Muir
Severity of Clostridium difficile-associated diarrhea in solid organ transplant patients.
Transplant infectious disease : an official journal of the Transplantation Society 2007;9(4):276-80.
2006: Andrew J Muir; John G McHutchison
Growth factors during HCV therapy may be "cost-effective", but are they "effective"?
Hepatology (Baltimore, Md.) 2006;44(6):1400-3.
2006: Meera Ramamurthy; Andrew J Muir
Treatment of hepatitis C in special populations.
Clinics in liver disease 2006;10(4):851-65.
2006: Charles D Scales; Steve Fein; Andrew J Muir; Don C Rockey
Clinical utilization of digital rectal examination and fecal occult blood testing upon hospital admission.
Journal of clinical gastroenterology 2006;40(10):913-8.
2006: Michael A Heneghan; Michael L Allan; Jeffrey D Bornstein; Andrew J Muir; David A Tendler
Utility of thiopurine methyltransferase genotyping and phenotyping, and measurement of azathioprine metabolites in the management of patients with autoimmune hepatitis.
Journal of hepatology 2006;45(4):584-91.
2006: Andrew J Muir; Pamela B Sylvestre; Don C Rockey
Interferon gamma-1b for the treatment of fibrosis in chronic hepatitis C infection.
Journal of viral hepatitis 2006;13(5):322-8.
2006: Keyur Patel; Andrew J Muir; John G McHutchison
Diagnosis and treatment of chronic hepatitis C infection.
BMJ (Clinical research ed.) 2006;332(7548):1013-7.
2005: Andrew J Muir
HCV genotype 2 and 3 infections: what is the optimal duration for peginterferon alpha-2b and ribavirin therapy?
Nature clinical practice. Gastroenterology & hepatology 2005;2(12):568-9.
2005: Cynthia A Moylan; Andrew J Muir
Treatment of hepatitis C in special populations.
Clinics in liver disease 2005;9(4):567-77, v.
2005: Steven L Condron; Michael A Heneghan; Keyur Patel; Anouk Dev; John G McHutchison; Andrew J Muir
Effect of donor age on survival of liver transplant recipients with hepatitis C virus infection.
Transplantation 2005;80(1):145-8.
2004: Andrew J Muir; Jeffrey D Bornstein; Paul G Killenberg
Peginterferon alfa-2b and ribavirin for the treatment of chronic hepatitis C in blacks and non-Hispanic whites.
The New England journal of medicine 2004;350(22):2265-71.
2003: Keyur Patel; Anouk Dev; Andrew J Muir; John G McHutchison
Ribavirin as maintenance therapy for hepatitis C patients: an interim peacekeeper?
Hepatology (Baltimore, Md.) 2003;38(1):21-4.
2003: T D Schmidt; Andrew J Muir
A case of electrical storm in a liver transplant patient.
Transplantation proceedings 2003;35(4):1437-8.
2003: Michael A Heneghan; Janet E Tuttle-Newhall; Paul V Suhocki; Andrew J Muir; Michael Morse; Jeffrey D Bornstein; Pamela B Sylvestre; Bradley Collins; Paul C Kuo; Don C Rockey
De-novo cholangiocarcinoma in the setting of recurrent primary sclerosing cholangitis following liver transplant.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2003;3(5):634-8.
2003: Keyur Patel; Andrew J Muir; John G McHutchison
Validation of a simple predictive model for the identification of mild hepatic fibrosis in chronic hepatitis C patients.
Hepatology (Baltimore, Md.) 2003;37(5):1222; author reply 1222-3.
2002: Andrew J Muir; Linda L Sanders; Michael A Heneghan; Paul C Kuo; William E Wilkinson; Dawn Provenzale
An examination of factors predicting prioritization for liver transplantation.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2002;8(10):957-61.
2002: Andrew J Muir; James F Trotter
A survey of current liver biopsy practice patterns.
Journal of clinical gastroenterology 2002;35(1):86-8.
2002: Andrew J Muir; Dawn Provenzale
A descriptive evaluation of eligibility for therapy among veterans with chronic hepatitis C virus infection.
Journal of clinical gastroenterology 2002;34(3):268-71.
2001: Andrew J Muir; Lloyd J Edwards; Linda L Sanders; R R Bollinger; Mark J Koruda; D R Bachwich; Dawn Provenzale
A prospective evaluation of health-related quality of life after ileal pouch anal anastomosis for ulcerative colitis.
The American journal of gastroenterology 2001;96(5):1480-5.
2001: Andrew J Muir; Linda L Sanders; William E Wilkinson; Kenneth E Schmader
Reducing medication regimen complexity: a controlled trial.
Journal of general internal medicine 2001;16(2):77-82.
2000: Andrew J Muir
The natural history of hepatitis C viral infection.
Seminars in gastrointestinal disease 2000;11(2):54-61.